OBJECTIVE: Several bone marrow-derived cell populations have been identified that may possess angiogenic activity and contribute to vascular homeostasis in experimental studies. We examined the extent to which lower quantities of these circulating angiogenic cell phenotypes may be related to impaired vascular function and greater arterial stiffness. METHODS: We studied 1948 Framingham Heart Study participants (mean age, 66±9 years; 54% women) who were phenotyped for circulating angiogenic cells: CD34+, CD34+/KDR+, and early outgrowth colony forming units (CFU). Participants underwent non-invasive assessments of vascular function including peripheral arterial tone (PAT), arterial tonometry, and brachial reactivity testing. RESULTS: In unadjusted analyses, higher CD34+ and CD34+/KDR+ concentrations were modestly associated with lower PAT ratio (β=-0.052±0.011, P<0.001 and β=-0.030±0.011, P=0.008, respectively) and with higher carotid-brachial pulse wave velocity (β=0.144±0.043, P=0.001 and β=0.112±0.043, P=0.009), but not with flow-mediated dilation; higher CD34+ was also associated with lower carotid-femoral pulse wave velocity (β=-0.229±0.094, P=0.015). However, only the association of lower CD34+ concentration with higher PAT ratio persisted in multivariable analyses that adjusted for standard cardiovascular risk factors. In all analyses, CFU was not associated with measures of vascular function or arterial stiffness. CONCLUSIONS: In our large, community-based sample of men and women, circulating angiogenic cell phenotypes largely were not associated with measures of vascular function or arterial stiffness in analyses adjusting for traditional risk factors.
OBJECTIVE: Several bone marrow-derived cell populations have been identified that may possess angiogenic activity and contribute to vascular homeostasis in experimental studies. We examined the extent to which lower quantities of these circulating angiogenic cell phenotypes may be related to impaired vascular function and greater arterial stiffness. METHODS: We studied 1948 Framingham Heart Study participants (mean age, 66±9 years; 54% women) who were phenotyped for circulating angiogenic cells: CD34+, CD34+/KDR+, and early outgrowth colony forming units (CFU). Participants underwent non-invasive assessments of vascular function including peripheral arterial tone (PAT), arterial tonometry, and brachial reactivity testing. RESULTS: In unadjusted analyses, higher CD34+ and CD34+/KDR+ concentrations were modestly associated with lower PAT ratio (β=-0.052±0.011, P<0.001 and β=-0.030±0.011, P=0.008, respectively) and with higher carotid-brachial pulse wave velocity (β=0.144±0.043, P=0.001 and β=0.112±0.043, P=0.009), but not with flow-mediated dilation; higher CD34+ was also associated with lower carotid-femoral pulse wave velocity (β=-0.229±0.094, P=0.015). However, only the association of lower CD34+ concentration with higher PAT ratio persisted in multivariable analyses that adjusted for standard cardiovascular risk factors. In all analyses, CFU was not associated with measures of vascular function or arterial stiffness. CONCLUSIONS: In our large, community-based sample of men and women, circulating angiogenic cell phenotypes largely were not associated with measures of vascular function or arterial stiffness in analyses adjusting for traditional risk factors.
Authors: Stanley Y Shaw; Susan Cheng; L Adrienne Cupples; Martin G Larson; Elizabeth L McCabe; Julius S Ngwa; Ying A Wang; Roderick P Martin; Rachael J Klein; Basma Hashmi; Olujimi A Ajijola; Evan Lau; Christopher J O'Donnell; Ramachandran S Vasan; Kenneth S Cohen; Thomas J Wang Journal: Circ Cardiovasc Genet Date: 2011-04-14
Authors: T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner Journal: Science Date: 1997-02-14 Impact factor: 47.728
Authors: Naomi M Hamburg; Michelle J Keyes; Martin G Larson; Ramachandran S Vasan; Renate Schnabel; Moira M Pryde; Gary F Mitchell; Jacob Sheffy; Joseph A Vita; Emelia J Benjamin Journal: Circulation Date: 2008-05-05 Impact factor: 29.690
Authors: Georg Schlieper; Mihail Hristov; Vincent Brandenburg; Thilo Krüger; Ralf Westenfeld; Andreas H Mahnken; Eray Yagmur; Georg Boecker; Nicole Heussen; Ulrich Gladziwa; Markus Ketteler; Christian Weber; Jürgen Floege Journal: Nephrol Dial Transplant Date: 2008-03-19 Impact factor: 5.992
Authors: L Sibal; A Aldibbiat; S C Agarwal; G Mitchell; C Oates; S Razvi; J U Weaver; J A Shaw; P D Home Journal: Diabetologia Date: 2009-05-30 Impact factor: 10.122
Authors: Gary F Mitchell; Helen Parise; Emelia J Benjamin; Martin G Larson; Michelle J Keyes; Joseph A Vita; Ramachandran S Vasan; Daniel Levy Journal: Hypertension Date: 2004-05-03 Impact factor: 10.190
Authors: Rian Q Landers-Ramos; Ryan M Sapp; Daniel D Shill; James M Hagberg; Steven J Prior Journal: Compr Physiol Date: 2019-03-14 Impact factor: 8.915
Authors: Leni Moldovan; Mirela Anghelina; Taylor Kantor; Desiree Jones; Enass Ramadan; Yang Xiang; Kun Huang; Arunark Kolipaka; William Malarkey; Nima Ghasemzadeh; Peter J Mohler; Arshed Quyyumi; Nicanor I Moldovan Journal: PLoS One Date: 2014-04-23 Impact factor: 3.240
Authors: Francisco Rodríguez-Esparragón; Laura B Torres-Mata; Juan Carlos López-Fernández; Laura Cappiello; Jesús M González-Martín; Bernardino Clavo; Jaime A Serna-Gómez; Lidia Estupiñán-Quintana; Cristina Torres-Ascensión; Jesús Villar Journal: BMC Cardiovasc Disord Date: 2022-03-21 Impact factor: 2.298